drugset / Trial / NCT01861847

7-Keto DHEA for the Treatment of PTSD

NCT01861847 ↗

Phase 2 Completed 71 enrolled Humanetics Corporation
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing symptoms of Post-Traumatic Stress Disorder (PTSD).

Timeline

Start
2013-02
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator 7-Keto Dehydroepiandrosterone Small molecule 100 mg Oral